Answer
No. It improves altered CFTR protein processing and function but does not remove the underlying gene variants or replace wider cystic-fibrosis care.
Sources for this answer
- Orkambi 150 mg/188 mg granules in sachet — Current selected SmPCemc · Summary of Product Characteristics
- Orkambi 200 mg/125 mg film coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.